# Biomarkers in Neurodegenerative Diseases

> **NCT04055532** · — · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Mild Cognitive Impairment (MCI)
- Alzheimer Disease (AD)
- Dementia With Lewy Bodies (DLB)
- Frontotemporal Lobar Degeneration (FTLD)
- Parkinsons Disease With Dementia (PDD)
- Transient Epileptic Amnesia (TEA)
- Temporal Lobe Epilepsy (TLE)
- Spinocerebellar Ataxias (SCA)
- HIV Associated Neurocognitive Disorder (HAND)
- Amyotrophic Lateral Sclerosis (ALS)
- Primary Lateral Sclerosis (PLS)

## Interventions

- **OTHER:** Neuraceq

## Key facts

- **NCT ID:** NCT04055532
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of regulatory approval
- **Last updated:** 2019-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04055532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04055532, "Biomarkers in Neurodegenerative Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04055532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*